Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05823870
What this trial is testing

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component(Empagliflozin and Metformin) in Healthy Adult Volunteers in Fast Condition.

Who this might be right for
Healthy Subjects
Dong Wha Pharmaceutical Co. Ltd. 32
Early research (Phase 1)Study completedNCT06547554
What this trial is testing

A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants

Who this might be right for
Bacterial Infections
Qpex Biopharma, Inc. 60
Early research (Phase 1)Looking for participantsNCT07361237
What this trial is testing

A Phase l Clinical Study to Evalute the Safety,Tolerability,Pharmacokinetic Characteristics,and Preliminary Anti-tumor Efficacy of HJ-004-02 Tablets in Patients With Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutations

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Tongji University 36
Testing effectiveness (Phase 2)Study completedNCT04417972
What this trial is testing

The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.

Who this might be right for
Endometriosis
Jiangsu HengRui Medicine Co., Ltd. 179
Early research (Phase 1)UnknownNCT04942301
What this trial is testing

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

Who this might be right for
Advanced or Metastatic NSCLC
Jiangsu Simcere Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03728634
What this trial is testing

Evaluate the Safety and Tolerability, as Well as the Pharmacokinetic and Pharmacodynamic Profiles of Single and Multiple Doses of Eplontersen Administered Subcutaneously to Healthy Volunteers and Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR ).

Who this might be right for
Healthy VolunteershATTR Amyloidosis
Ionis Pharmaceuticals, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT04462198
What this trial is testing

Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss

Who this might be right for
Sensorineural Hearing Loss
Contineum Therapeutics 28
Testing effectiveness (Phase 2)Looking for participantsNCT05934513
What this trial is testing

GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Genfleet Therapeutics (Shanghai) Inc. 95
Early research (Phase 1)Study completedNCT06156280
What this trial is testing

A Clinical Study of TQH2929 in Healthy Adult Subjects

Who this might be right for
Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 40
Early research (Phase 1)Study completedNCT06406348
What this trial is testing

Trial to Assess Safety, Tolerability and Pharmacokinetics of ALIA-1758 in Healthy Participants

Who this might be right for
Alzheimer Disease
AbbVie 53
Early research (Phase 1)Study completedNCT00888108
What this trial is testing

Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer

Who this might be right for
Solid Tumor
Abbott 41
Testing effectiveness (Phase 2)Study completedNCT03288324
What this trial is testing

Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus

Who this might be right for
Cutaneous LupusSystemic Lupus Erythematosus
Children's Hospital Medical Center, Cincinnati 13
Testing effectiveness (Phase 2)Looking for participantsNCT06682780
What this trial is testing

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumor
LaNova Medicines Limited 320
Early research (Phase 1)Active Not RecruitingNCT06933459
What this trial is testing

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults

Who this might be right for
Dyslipidemia
AJU Pharm Co., Ltd. 60
Early research (Phase 1)Study completedNCT06253546
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia

Who this might be right for
Schizophrenia
Teva Branded Pharmaceutical Products R&D LLC 24
Testing effectiveness (Phase 2)Study completedNCT00711997
What this trial is testing

Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Anchiano Therapeutics Israel Ltd. 9
Early research (Phase 1)Study completedNCT04631874
What this trial is testing

A Clinical Trial to Compare Pharmacokinetics of the "CDFF0318" and "Champix Tab. 1mg"

Who this might be right for
Smoking CessationPharmacokinetics
CTC Bio, Inc. 32
Early research (Phase 1)Study completedNCT07319559
What this trial is testing

Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

Who this might be right for
Mixed Dyslipidemia
Daewon Pharmaceutical Co., Ltd. 55
Early research (Phase 1)Study completedNCT05238701
What this trial is testing

A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects

Who this might be right for
Huntington DiseaseTardive Dyskinesia
Luye Pharma Group Ltd. 104
Testing effectiveness (Phase 2)UnknownNCT01505907
What this trial is testing

Pharmacokinetic Study of CXB909 in Healthy Male Subjects

Who this might be right for
Healthy
CeNeRx BioPharma Inc. 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation